<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56983">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01855633</url>
  </required_header>
  <id_info>
    <org_study_id>2013-019</org_study_id>
    <nct_id>NCT01855633</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation in Patients With Hemiplegic Stroke</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dongtan Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dongtan Sacred Heart Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke is one of the major causes of death in the World. Many stroke survivors may suffer
      from long-term sequelae of stroke such as hemiplegia. The effects of rehabilitation therapy
      are limited. The development of new treatment strategies is essential. Repetitive
      transcranial magnetic stimulation (rTMS) is a non-invasive method to stimulate the focal
      area of the brain for restoring brain function.  The aim of this study is to investigate the
      therapeutic effect of rTMS on the motor recovery in patients with hemiplegic stroke.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Keyboard tapping test</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participants will be asked to tap a key of a computer keyboard as fast as possible in five seconds. They will be asked to do three times. We will measure the number of tapping. The primary outcome will be the averaged data of the numbers.This will be done before and after 5-day rTMS intervention.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Tradtional Theta burst stimulation (TBS) rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive continuous theta burst stimulation (cTBS) rTMS to contralesional hemisphere based on a previous study (Huang et al., 2005)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified TBS rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive modified cTBS rTMS to contralesional hemisphere based on a previous study (Nyffeler et al., 2006)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will receive sham cTBS rTMS to contralesional hemisphere.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Traditional Theta burst stimulation (TBS)</intervention_name>
    <arm_group_label>Tradtional Theta burst stimulation (TBS) rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Modified TBS rTMS</intervention_name>
    <arm_group_label>Modified TBS rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham rTMS</intervention_name>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stroke patients with motor weakness

          -  Medical research council (MRC) grade 0-4

          -  More than 2 weeks after stroke onset

          -  Age 18 years and older

          -  Able to provide consent for the protocol

        Exclusion Criteria:

          -  History of previous symptomatic stroke

          -  pregnant women

          -  Persons with surgically or traumatically implanted foreign bodies such as a
             pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside
             the skull or eyes (other than dental appliances or fillings), intracardiac lines that
             may pose a physical hazard during magnetic stimulation will also be excluded

          -  Patients with history of seizure disorder or epilepsy

          -  Subjects without the capacity to give informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Suk Yun Kang, MD, PhD</last_name>
    <phone>82-31-8086-2310</phone>
    <email>sukyunkang@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ah-Young Jun, MD, MS</last_name>
    <phone>82-31-8086-2310</phone>
    <email>ayjun@hallym.or.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dongtan Sacred Heart Hospital</name>
      <address>
        <city>Hwaseong Si</city>
        <state>Gyeonggi-Do</state>
        <zip>445-170</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suk Yun Kang, MD, PhD</last_name>
      <phone>82-31-8086-2310</phone>
      <email>sukyunkang@hanmail.net</email>
    </contact>
    <contact_backup>
      <last_name>Ah-Young Jun, MD, MS</last_name>
      <phone>82-31-8086-2310</phone>
      <email>ayjun@hallym.or.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Suk Yun Kang, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 23, 2013</lastchanged_date>
  <firstreceived_date>May 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dongtan Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Suk Yun Kang</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
